Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
Ju F, Luo Y, Lin C, Jia X, Xu Z, Tian R, Lin Y, Zhao M, Chang Y, Huang X, Li S, Ren W, Qin Y, Yu M, Jia J, Han J, Luo W, Zhang J, Fu G, Ye X, Huang C, Xia N.
Ju F, et al. Among authors: yu m.
J Immunother Cancer. 2022 Jun;10(6):e004762. doi: 10.1136/jitc-2022-004762.
J Immunother Cancer. 2022.
PMID: 35688558
Free PMC article.